|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
47,500,000 |
Market
Cap: |
1.95(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$35.77 - $65 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Amphastar Pharmaceuticals is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing and selling generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient (API) products. Co.'s reportable segments are: finished pharmaceutical products, which manufactures, markets and distributes Primatene Mist®, glucagon, enoxaparin, naloxone, phytonadione, lidocaine, epinephrine, various critical and non-critical care drugs; and API, which manufactures and distributes recombinant human insulin API and porcine insulin API for external customers and internal product development.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
32,136 |
465,065 |
655,744 |
1,062,982 |
Total Sell Value |
$1,503,716 |
$26,033,932 |
$35,438,128 |
$50,015,597 |
Total People Sold |
3 |
7 |
9 |
11 |
Total Sell Transactions |
5 |
17 |
34 |
71 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Zhou Rong |
EVP, Production Center |
|
2023-05-18 |
4 |
OE |
$14.40 |
$144,000 |
D/D |
10,000 |
97,598 |
|
- |
|
Petersen Floyd F. |
Director |
|
2023-05-17 |
4 |
S |
$43.13 |
$215,655 |
D/D |
(5,000) |
80,117 |
|
-6% |
|
Deflin Gayle |
Director |
|
2023-05-15 |
4 |
S |
$43.15 |
$64,728 |
D/D |
(1,500) |
8,682 |
|
-9% |
|
Zasloff Michael A |
Director |
|
2023-05-15 |
4 |
S |
$42.18 |
$316,335 |
D/D |
(7,500) |
43,869 |
|
-9% |
|
Prins Richard K |
Director |
|
2023-05-15 |
4 |
S |
$43.50 |
$217,502 |
D/D |
(5,000) |
44,342 |
|
-9% |
|
Prins Richard K |
Director |
|
2023-05-15 |
4 |
OE |
$16.69 |
$83,450 |
D/D |
5,000 |
49,342 |
|
- |
|
Prins Richard K |
Director |
|
2023-05-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
44,342 |
|
- |
|
Prins Richard K |
Director |
|
2023-05-12 |
4 |
S |
$42.06 |
$210,323 |
D/D |
(5,000) |
47,342 |
|
-10% |
|
Prins Richard K |
Director |
|
2023-05-12 |
4 |
OE |
$16.69 |
$83,450 |
D/D |
5,000 |
52,342 |
|
- |
|
Peters William J |
CFO, EVP & Treasurer |
|
2023-04-17 |
4 |
AS |
$42.35 |
$238,515 |
D/D |
(5,632) |
105,148 |
|
28% |
|
Peters William J |
CFO, EVP & Treasurer |
|
2023-04-17 |
4 |
OE |
$13.35 |
$75,187 |
D/D |
5,632 |
110,780 |
|
- |
|
Peters William J |
CFO, EVP & Treasurer |
|
2023-04-13 |
4 |
AS |
$42.35 |
$206,160 |
D/D |
(4,868) |
105,148 |
|
28% |
|
Peters William J |
CFO, EVP & Treasurer |
|
2023-04-13 |
4 |
OE |
$13.35 |
$64,988 |
D/D |
4,868 |
110,016 |
|
- |
|
Liawatidewi Yakob |
EVP Corp Admin Center |
|
2023-04-13 |
4 |
AS |
$41.00 |
$477,748 |
D/D |
(11,494) |
69,215 |
|
28% |
|
Liawatidewi Yakob |
EVP Corp Admin Center |
|
2023-04-13 |
4 |
OE |
$20.23 |
$232,524 |
D/D |
11,494 |
80,709 |
|
- |
|
Peters William J |
CFO, EVP & Treasurer |
|
2023-04-10 |
4 |
AS |
$40.35 |
$404,791 |
D/D |
(10,032) |
105,148 |
|
32% |
|
Peters William J |
CFO, EVP & Treasurer |
|
2023-04-10 |
4 |
OE |
$13.35 |
$133,927 |
D/D |
10,032 |
115,180 |
|
- |
|
Liawatidewi Yakob |
EVP Corp Admin Center |
|
2023-04-10 |
4 |
AS |
$40.00 |
$200,000 |
D/D |
(5,000) |
69,215 |
|
32% |
|
Liawatidewi Yakob |
EVP Corp Admin Center |
|
2023-04-10 |
4 |
OE |
$20.23 |
$101,150 |
D/D |
5,000 |
74,215 |
|
- |
|
Liawatidewi Yakob |
EVP Corp Admin Center |
|
2023-03-17 |
4 |
D |
$36.29 |
$60,713 |
D/D |
(1,673) |
69,215 |
|
- |
|
Zhou Rong |
EVP, Production Center |
|
2023-03-17 |
4 |
D |
$36.29 |
$68,987 |
D/D |
(1,901) |
87,598 |
|
- |
|
Peters William J |
CFO, EVP & Treasurer |
|
2023-03-17 |
4 |
D |
$36.29 |
$151,039 |
D/D |
(4,162) |
105,148 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2023-03-17 |
4 |
D |
$36.29 |
$255,917 |
I/I |
(7,052) |
1,455,602 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2023-03-17 |
4 |
D |
$36.29 |
$572,221 |
D/D |
(15,768) |
2,078,718 |
|
- |
|
Liawatidewi Yakob |
EVP Corp Admin Center |
|
2023-03-16 |
4 |
D |
$37.60 |
$60,912 |
D/D |
(1,620) |
70,888 |
|
- |
|
954 Records found
|
|
Page 4 of 39 |
|
|